Search Results

Three Finnish life science experts – Abacus Diagnostica, a frontrunner in molecular testing and rapid PCR test systems, Kaivogen, a specialist in immunoassays and antibody tests, and Labrox, an innovator of high technology laboratory instruments and diagnostic readers – announced in September 2021 that they are joining forces to form a global diagnostics pioneer.

Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) announced that additional data from the ABACUS-1 trial has been accepted for presentation at the Association for Research in Vision

Three Finnish biotech companies - Abacus Diagnostica, Kaivogen and Labrox - are joining forces to form an international frontrunner in in vitro diagnostics.

Abacus Diagnostica is a small Finnish company developing and manufacturing assays and devices for rapid molecular diagnostics.

Carestream Health recently secured an agreement with Distribuidora Diagnostica Medica SAC, a leading distributor of radiology solutions in Peru, to convert the latter’s customers and install base to Carestream products.

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) announced that results from the ABACUS study of KIO-301 in patients with late-stage

Today, on National Diabetes Alert Day, Abacus Health Solutions announces the results of a cost savings analysis of their patented Diabetes Care Rewards Program, which incentivizes long-term health behaviors and dramatically reduces costs of diabetes care for insurers, employers and individuals.

Global molecular diagnostics innovator Sense Biodetection announced it has entered into a strategic agreement with Abacus dx for the non-exclusive distribution in Australia and New Zealand of Sense’s Veros instrument-free, point-of-care molecular testing platform.